Patents expiring in 2033

US 8563022

Particles for cell targeting

The Board of Regents of the University of Texas System · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563035

Oral tablet compositions of dexlansoprazole

Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563039

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

Anika Therapeutics S.r.l. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563314

Methods and compositions for modulating PD1

Sangamo Biosciences, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563503

Antibiotic, its nucleotide sequence, methods of construction and uses thereof

PROTEIN DESIGN LAB, LTD. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563515

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563569

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563575

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563573

Azaindole derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563576

Tri-cyclic pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563593

Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563599

Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563614

Use of treprostinil to treat neuropathic diabetic foot ulcers

United Therapeutics Corporation · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563691

Lysosomal targeting peptides and uses thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563618

Skin external preparation having excellent stability

KURARAY CO., LTD. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563692

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563651

Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

Nektar Therapeutics · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563730

Pyrazole and fused pyrazole glucokinase activators

Takeda San Diego, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8563731

Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

Almirall, S.A. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2651400

ORALE RETARD-DARREICHUNGSFORMEN VON SCHWER LÖSLICHEN ARZNEIMITTELN UND IHRE VERWENDUNG

CELGENE CORP [US] · Granted Wed Oct 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2870399

POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES

ALK ABELLO AS [DK] · Granted Thu Oct 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568977

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569028

Method for encapsulation of microparticles

The United States of America, as represented by the Secretary of the Agriculture · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569379

Use of rasagiline for the treatment of olfactory dysfunction

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569380

Oligomer-tricyclic conjugates

Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568769

Particle-containing complex porous materials

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568713

Super fast-acting insulin compositions

HALOZYME, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568721

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568739

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569225

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569337

Tri-cyclic pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569351

Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

Theravance, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569249

Method for inhibiting activation of macrophages

China Medical University · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569377

Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569253

Methods and compositions for gene inactivation

Sangamo Biosciences, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569242

Method of treating degenerative disorders of the nervous system

The Regents of the University of California · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569343

Oligomer-opioid agonist conjugates

Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568756

Inhibition of quorum sensing-mediated processes in bacteria

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569448

NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders

GRACE LABORATORIES, LLC · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569340

AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568714

Lys K endolysin is synergistic with lysostaphin against MRSA

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8568705

Method for preparing branched functionalized polymers using branched polyol cores

Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8569320

Topical composition for the treatment of actinic keratosis

Almirall Hermal GmbH · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2656851

Semuloparin zur Verbesserung der Überlebenschance von Krebspatienten

AVENTIS PHARMA SA [FR] · Granted Wed Oct 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2013289070

Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines

BAUSCH & LOMB [US] · Granted Thu Oct 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8575192

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8575375

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8574545

Labeled iodinated tropane formulation

Alseres Pharmaceuticals, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)